Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Gideon Dosunmu

GI Oncology · Emory Hospital Midtown

View

Dr. Tyler Johnson

GI Oncology · Stanford

View

Dr. James Cleary

GI Oncology · Dana-Farber Cancer Institute

View

Dr. Thorvardur Halfdanarson

GI Oncology · Mayo Clinic Rochester

View

Dr. Linette Bosques

GI Oncology · DFCI/MGB

View

Dr. Shikha Jain

GI Oncology · University Illinois

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Saad Usmani

Myeloma · MSK

View

Dr. Kamal Menghrajani

Leukemia · MGH

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    DRDr. Diane Reidy-Lagunes
    Leading Voice

    Dr. Diane Reidy-Lagunes

    Hematology & Oncology · Gastrointestinal Oncology
    Duke University
    dianereidylagunes

    Research

    Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy.

    2025

    Via Journal of the National Cancer Institute

    Jan 18, 2025Journal Article

    Adjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma.

    ​

    Written by 1 Roon author & 28 others

    Via Annals of Surgical Oncology

    Research

    Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms.

    2025

    Via medRxiv

    Research

    Loss of DAXX/ATRX Protein Expression Results in Ischemia Resistance and Radiation Sensitivity in Pancreatic Neuroendocrine Tumor Cells and Is Associated with Improved Response to Trans-Arterial Radioembolization.

    2025

    Via Neuroendocrinology

    Research

    Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.

    2025

    Via JCO Precision Oncology

    Research

    Safety and efficacy of Yttrium-90 transarterial radioembolization of neuroendocrine liver metastasis - A retrospective single-institution study.

    2025

    Via European Journal of Radiology

    Research

    Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy

    2025

    Via Journal of the National Cancer Institute

    Jan 18, 2025Journal Article

    Adjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma.

    ​

    Written by 1 Roon author & 28 others

    Via Annals of Surgical Oncology

    Research

    Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms

    2025

    Via medRxiv : the preprint server for health sciences

    Research

    Loss of DAXX/ATRX Protein Expression Results in Ischemia Resistance and Radiation Sensitivity in Pancreatic Neuroendocrine Tumor Cells and Is Associated with Improved Response to Trans-Arterial Radioembolization

    2025

    Via Neuroendocrinology

    Research

    Sequencing of Somatostatin-Receptor-Based Therapies in Neuroendocrine Tumor Patients.

    2024

    Via Journal of Nuclear Medicine

    Research

    Clinical utility of plasma cell-free DNA in pancreatic neuroendocrine neoplasms.

    2024

    Via Endocrine-Related Cancer

    Research

    Treatment of advanced BP-NETS with lanreotide autogel/depot vs placebo: the phase III SPINET study.

    2024

    Via Endocrine-Related Cancer

    Research

    A review of mitotane in the management of adrenocortical cancer.

    2024

    Via The Oncologist

    Research

    Sequencing of Somatostatin-Receptor-Based Therapies in Neuroendocrine Tumor Patients

    2024

    Via Journal of nuclear medicine : official publication, Society of Nuclear Medicine